The Treatment of Glabellar Frown Lines
NCT02096081
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
IncobotulinumtoxinA
DRUG:
OnabotulinumtoxinA
Sponsor
Merz North America, Inc.